Researchers have made more advancements in multiple sclerosis in the last five years than in the previous 70 years. Knowing ...

After years of legal wrangling surrounding Teva’s Copaxone, the latest hit to the lucrative multiple sclerosis drug comes in ...

Patients should stop taking glatiramer acetate and seek immediate medical attention by going to an emergency room or calling ...

The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.

The FDA has advised health care professionals and patients with multiple sclerosis that treatment with glatiramer acetate is ...

A woman who has polycystic ovary syndrome (PCOS) is calling for more support for patients after she paid more than £3,100 for ...

The U.S. Centers for Disease Control and Prevention (CDC) is urging health care workers to accelerate bird flu testing ...

A recent study by UC San Francisco has uncovered that menopause has a negative influence on several prodromal symptoms of Multiple Sclerosis, thus catalysing its progression. Multiple Sclerosis ...

Relapsing-remitting multiple sclerosis is an unpredictable disease marked by relapses and remissions, but there are options to help you.

Switching therapies is a common part of multiple sclerosis management and may be considered for several reasons.

This helps reduce inflammation and MS symptoms. Treatment may include: Healthcare professionals typically give high dose steroids through an IV once daily for 3 to 5 days. This usually occurs in ...